Use of T-VEC in early metastatic melanoma
Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands
21 Oct 2018
Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial...
Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, ...
21 Oct 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
4 Jul 2018
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma
Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Ch...
15 Jun 2018
Updates in melanoma from ASCO 2018
Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
4 Jun 2018
Editor’s Choice for May 2018
Prof Gordon McVie - Founding Editor, ecancer
21 May 2018
Reducing recurrence of advanced melanoma with pembrolizumab
Prof Alex Eggermont - Paris-Sud University, Paris, France
25 Apr 2018
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.
Prof Alex Eggermont - Paris-Sud University, Paris, France
25 Apr 2018
Lenalidomide with rituximab for mantle cell lymphoma
Prof Jia Ruan - Weill Cornell Medicine and New York Presbyterian Hospital, New Y...
11 Dec 2017
A biological perspective for personalising immunotherapies
Dr Tom Lillie - Head of European Clinical Development, MSD, London, UK
6 Dec 2017
Editor's Choice for November 2017
Prof Gordon McVie - Founding Editor, ecancer
4 Dec 2017
The promise of immunotherapy for elderly patients
Dr Alistair Greystoke - Newcastle University, Newcastle, UK
15 Nov 2017
